---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-104363"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2025-08-07T23:59:59+00:00"
generated_at: "2026-05-17T18:18:36.248235+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q2 revenue $345.3M (+11% YoY); raises FY 2025 Adj. EBITDA guidance to $140-150M

## Summary
- Revenue of $345.3M (+11% YoY); net loss narrowed to $3.8M from $23.3M.
- Adjusted EBITDA of $34.0M (+19% YoY); Free Cash Flow of $56.6M, a quarterly record.
- Clinician base grew 11% to 7,708 (net +173 in Q2); visit volumes up 12% to 2.2M.
- FY 2025 guidance: Adj. EBITDA raised to $140-150M (midpoint +$5M); revenue reiterated $1.40-1.44B.
- Q3 2025 guidance: revenue $345-365M, Adj. EBITDA $33-39M, Center Margin $105-119M.

## SEC filing metadata
- accession: 0000950170-25-104363
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2025-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/0000950170-25-104363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000095017025104363/lfst-20250807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-104363
- JSON: https://secwatch.observer/filing/0000950170-25-104363.json
- Plain text: https://secwatch.observer/filing/0000950170-25-104363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.